全国服务咨询热线:
15921799099
15921799099
全部多肽类型
•多肽混合库
•多肽文库
•单条多肽
•多肽（微）阵列
灵活定制参数
•规模：微克级至克级
•纯度：粗品至 95% 以上
•用途：仅用于研究（RUO）、符合 GLP 规范、预 GMP / 临床级
•常规合成长度：2‑50 个氨基酸
•包装载体：西林瓶、试管架、载玻片、多孔板、膜材
种类繁多的修饰方式
•磷酸化修饰
•非天然及稀有氨基酸修饰
•同位素标记多肽
•荧光标记
•生物素化
•环化修饰
•生物偶联
•更多其他修饰
为何选择 JPT？
•全球技术支持团队
•二十余年多肽合成行业经验
•严苛的环境、健康与伦理标准
•先进技术、顶尖设备与专业技术团队
商品化多肽产品
适用于免疫学、蛋白质组学、糖尿病、阿尔茨海默病等多个领域
抗原多肽与多肽混合库
•500 余种 PepMix 多肽混合库，数千种单一抗原多肽
•实验对照多肽：例如 CEFX、pp65、Ova
•病毒抗原：EB 病毒、人类疱疹病毒、新冠病毒、人类冠状病毒、巨细胞病毒、人乳头瘤病毒、水痘‑带状疱疹病毒等
•细菌抗原：结核分枝杆菌等
•基因载体：人腺病毒、黑猩猩腺病毒、腺相关病毒等
•肿瘤抗原：MUC1、PRAME/OIP4、NY‑ESO‑1、MART‑1、Wt1 等
单种多肽
•β‑淀粉样多肽
•细胞穿透肽
•化妆品多肽（DRPA）
•糖尿病相关多肽
•水凝胶形成多肽
•多肽亲和标签
•放射性配体与放射增敏剂
•转导增强肽
试剂盒与阵列
•定量蛋白质组学参考试剂盒、标准品及对照品
•酶底物套装
•玻璃基多肽微阵列
商品化多肽产品数量：2000 + 种
更多产品信息，请联系中国区域代理商：上海起发实验试剂有限公司
（注：本文内容基于品牌公开资料及行业常规信息整理，具体以品牌信息文档为准。）
🔖JPT Peptide Technologies GmbH热卖产品
货号 | 品名 | 规格 |
PM-CEFX-2 | CEFX Ultra SuperStim Pool | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-EBV-LMP2 | PepMix™ EBV (LMP2) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-OIP4 | PepMix Human (Prame/OIP4) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-PP65-1 | PepMix™ HCMVA （pp65） | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-CEFX-1 | CEFX Ultra SuperStim Pool | 15nmol(approx.25ug)/peptide |
PM-PD-L1 | PepMix Human (PD-L1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-VZV-gE | PepMix™ VZV (gE) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-CEF-S-3 | CEF Pool (standard) 15nmol>90％ | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-IE1 | PepMix™ HCMVA (IE-1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-PP65-2 | PepMix™ HCMVA (pp65) (>90％) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-CEF-E-3 | CEF Pool (extended) | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-EBV-BZLF1 | PepMix™ EBV (BZLF1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HIV-ENV | PepMix HIV-1 (ENV) Ultra | 25ug(approx.15nmol)/peptide |
PM-HPV16-E6 | PepMix™ HPV 16 （E6） | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HPV16-E7 | PepMix™ HPV 16 (E7) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MOG | PepMix Human (MOG) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-CEFT-3 | CEFT Pool (15 nmol, >90%) | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-CEFT-MHC-II-1 | CEFT MHC-II Pool | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-CEFX-3 | CEFX Ultra SuperStim Pool MHC-II Subset (15 nmol, >70%) | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-CyCMV-UL55 | PepMix CyCMV (GP-UL55) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-BMRF1 | PepMix™ EBV (BMRF1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA1 | PepMix™ EBV (EBNA1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA3a | PepMix™ EBV (EBNA3a) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA3b | PepMix™ EBV (EBNA3b) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA3c | PepMixEBV（EBNA3c） | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HBV-CPULTRA | PepMix™ HBV (Capsid Protein) Ultra | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HRSVB-FGF0 | PepMix™ HRSVB (Fusion Glycoprotein F0) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HSV2-gC | PepMix HSV2 (gC) | 25ug(approx.15nmol)/peptide |
PM-HSV2-gD | PepMix HSV2 (gD) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-INFA-HAIndo | PepMix™ Influenza A (HA/Indonesia (H5N1)) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-INFB-NAAUT21 | PepMix™ Influenza B (NA/H0N0/Austria/2021) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MYCTU-AG85B | PepMix M. tuberculosis (Ag85B) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MYCTU-CFP10 | PepMix M. tuberculosis (CFP-10) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MYCTU-ESAT6 | PepMix M. tuberculosis (ESAT-6) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-WCPV-S-RBD-1 | PepMix™ SARS-CoV-2 (S-RBD) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-ACTS | PepMix™ Human (Actin) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-CEA | PepMix™ Human (CEA) | 25ug(approx.15nmol) |
PM-CEF-E-1 | CEF Pool (extended) | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-CEF-S-4 | CEF Pool (standard) | 120nmol/peptide |
PM-CEFSX-2 | CEFSX Ultra SuperStim Pool | 15nmol(approx.25ug)/peptide |
PM-CEFT-MHC-II-2 | CEFT MHC-II Pool | 120nmol(approx.200ug)/peptide |
PM-CEFT-MHC-II-3 | CEFT MHC-II Pool | 15nmol(approx.25ug)/peptide |
PM-CEFT-MHC-II-4 | CEFT MHC-II Pool | 120nmol/peptide |
PM-CEFX-4 | CEFX Ultra SuperStim Pool MHC-I Subset | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-CLD6 | PepMix™ Human (Claudin-6) * Protein ID: P56747 | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-BARF1 | PepMix™ EBV (BARF1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-BMLF1 | PepMix™ EBV (BMLF1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-BRLF1 | PepMix™ EBV (BRLF1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA-LP | PepMix™ EBV (EBNA-LP) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-EBNA2 | PepMix™ EBV (EBNA2) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-GP350/GP340 | PepMix EBV (GP350/GP340) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-EBV-LMP1 | PepMixEBV（LMP1） | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HBV-LEPULTRA | PepMix™ HBV (LEP) Ultra | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HIV-GAG | PepMix™ HIV-1 (GAG) Ultra | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HIV-POL | PepMix HIV-1 (POL) Ultra | 25ug(approx.15nmol)/peptide |
PM-HPV16-E1 | PepMix HPV16 (E1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-HRSVA-FGF0 | PepMix HRSVA (Fusion Glycoprotein F0) | 25ug(approx.15nmol)/peptide |
PM-HSV2-E3 | PepMix™ HSV2 (E3 ICP0)(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) | 25ug |
PM-HSV2-gB | PepMix HSV2 (gB) | 25ug(approx.15nmol)/peptide |
PM-INF-M1U01-1 | PepMix Influenza A (M1) Ultra | 25ug(approx.15nmol)/peptide |
PM-INFA_NA | PepMix Influenza A (Neuroamidase /California (H1N1) *C7FH14 | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-INFA-HADAR21-1 | PepMix Influenza A (HA/H3N2/Darwin/2021) | 25ug(approx.15nmol)/peptide |
PM-INFA-HADAR21-2 | PepMix™ Influenza A (HA/H3N2/Darwin/2021) | 25ug |
PM-INFA-HAGUA23 | PepMix Influenza A (HA/H5N1/Guanajuato/2023) | 25ug(approx.15nmol)/peptide |
PM-INFA-NADAR21 | PepMix Influenza A (NA/H3N2/Darwin/2021) | 25ug(approx.15nmol)/peptide |
PM-INFA-NPPR | PepMix™ Influenza A (NP/Puerto Rico/8/1934 H1N1) | 25 ug (approx. 15 nmol) |
PM-INFB-HAAUT21-1 | PepMix™ Influenza B (HA/H0N0/Austria/2021) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-INFB-HAPHU13-1 | PepMix™ Influenza B (HA/H0N0/Phuket/2013) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-KKLC1 | PepMix™ Human (KKLC1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MAGEA3 | PepMix™ Human (MAGEA3) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MAGEA4 | PepMix Human (MAGEA4) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MAGEC1 | PepMix™ Human (MAGEC1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-MEASW-HGP | PepMix Measles virus (Hemagglutinin glycoprotein) | 25ug(approx.15nmol)/peptide |
PM-P53 | PepMix Human (P53) | 25ug(approx.15nmol)/peptide |
PM-Pan-CMVselect-1 | PepMix™ Pan-CMV Select | 15nmol(approx.25ug)/peptideforstimulationof2,5x108cells |
PM-Pan-EBVselect-1 | PepMix Pan-EBV Select | 15nmol(approx.25ug)/peptide |
PM-Pan-PXVselect-1 | PepMix Pan-Poxviridae Select | 15nmol(approx.25ug)/peptide |
PM-SARS2-SMUT09-1 | PepMix SARS-CoV-2 (Spike B.1.1.529 / BA.2 / Omicron) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-Survivin | PepMix Human (Survivin) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-TARP | PepMix™ Human (TCRgamma alternate reading frame protein TARP) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-WCPV-S-1 | PepMix™ SARS-CoV-2 (Spike Glycoprotein) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-WCPV-S-2 | PepMix™ SARS-CoV-2 (Spike Glycoprotein) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-WCPV-S-SU1-1 | PepMix™ SARS-CoV-2 (Spike Glycoprotein SUB1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
SP-CAT-001-1 | Lysine Peptide | 10mg |
SP-CAT-002-1 | Cysteine Peptide | 10mg |
SP-MHCI-0005-3 | Antigen Peptide CMV pp65 - HLA-A*0201 (NLVPMVATV) | 10mg |
SP-MHCI-0006-1 | Antigen Peptide MART-1 (Leu26) - HLA-A*0201 (ELAGIGILTV) | 50ug |
SP-MHCI-0118-1 | Antigen Peptide Envelope glycoprotein H-2 Ld (SPSYVYHQF) | 50ug |
Custom-peptide | Sequence: WDCLDNRIGRRQCVKL,Purity: >70% | 1mg |
OF-23338 | Customized PepMix | ea |
OF-31957 | Gedys-PA-4509 SpikeTides L - peptides | 24pc. |
PM-AAV2-VP1 | PepMix AAV2 (Capsid Protein VP1) | 25ug(approx.15nmol)/peptide |
PM-AAV5-CP | PepMix AAV5 (Capsid Protein) | 25ug(approx.15nmol)/peptide |
PM-AAV8-CP | PepMix™ AAV8 (capsid protein) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-ASPFU-CRF1 | PepMix™ Aspergillus fumigatus (Probable glycosidase crf1) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-BKV-LTA | PepMix BKV (large T antigen) | 25ug(approx.15nmol)/peptide |
PM-BKV-VP1 | PepMix BKV (capsid protein VP1) | 25ug(approx.15nmol)/peptide |
PM-C-EBV-1 | PepMix Collection EBV (2x1ug/peptide) | 2xaliquotsofeachpeptidepool(1ug/peptide/pool) |
PM-C-SARS2-WSP-2 | PepMix Collection SARS-CoV-2 Wuhan Structural Proteins | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
PM-C1 | PepMix™ Human (HLA classI Ig-like C1 type domain) | 25ug(approx.15nmol)/peptide(forstimulationofupto2,5x108cells) |
电话
微信
当前位置：
地址：上海浦东川沙镇川沙路6619号上海起发实验试剂有限公司
邮箱：xs1@78bio.com
传真：021-50724961